Dr. Eng: Egfr-Directed Therapy And Mutational Status

What targeted therapies are used for people with the EGFR mutation?

You and Lung Cancer

Acquired resistance to anti-EGFR therapy in colorectal cancer

Mechanisms of Resistance to Upfront EGFR-Targeted Therapy

How do doctors treat lung cancer with EGFR mutations?

You and Lung Cancer

EGFR Mutations in Patients With Lung Cancer

Targeted Oncology

GRACEcastUC-022_Lung_What is an Inherited T790M EGFR Mutation, and What Does It Mean?

GRACE - Global Resource for Advancing Cancer Education

Dr. West on FDA Approval of Afatinib in NSCLC With Rare EGFR Mutations

Dr. Yu on Treatments for EGFR-Mutant Lung Cancer

Individual Treatments for Individual EGFR Mutations

GRACE - Global Resource for Advancing Cancer Education

Dr. Scagliotti Discusses EGFR Mutations in NSCLC

GRACEcastUC104_Lung_Dr. Goldberg on EGFR Mutation After Starting Chemo

GRACE - Global Resource for Advancing Cancer Education

Dr. Lynch on Targeting EGFR Mutation Subtypes in Lung Cancer

Dr. Goldman on Targeted Therapy Options for EGFR-, ALK-, and ROS1-Mutated NSCLC

Do immune checkpoint inhibitors work in EGFR mutant lung cancer?

Current Role of Immunotherapy in EGFR-Mutant Lung Cancer

Targeted Oncology

EGFR Breakout Video Targeted Therapies 2017

GRACE - Global Resource for Advancing Cancer Education

How to Understand EGFR T790M Mutations | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Case Based Panel Discussion - EGFR and High PDL1 What is the Role of Immunotherapy in Treatment?

GRACE - Global Resource for Advancing Cancer Education

Dr. Wakelee on First-Line Therapy for EGFR-Mutant Lung Cancer

Response to systemic anti-cancer therapy in uncommon EGFR mutations